Inhibition of EGFR-STAT3 signaling with erlotinib prevents carcinogenesis in a chemically-induced mouse model of oral squamous cell carcinoma

類似資料

• TARGETING STAT3 ABROGATES EGFR INHIBITOR RESISTANCE IN CANCER
  著者:: Sen, Malabika, 等
  出版事項: (2012)
• Honokiol inhibits EGFR signaling and enhances the antitumor effects of EGFR inhibitors
  著者:: Leeman-Neill, Rebecca J., 等
  出版事項: (2010)
• Guggulsterone enhances head and neck cancer therapies via inhibition of signal transducer and activator of transcription-3
  著者:: Leeman-Neill, Rebecca J., 等
  出版事項: (2009)
• Targeting GPCR-mediated p70S6K activity may improve head and neck cancer response to cetuximab
  著者:: Bhola, Neil E., 等
  出版事項: (2011)
• Targeting TORC1/2 Enhances Sensitivity to EGFR Inhibitors in Head and Neck Cancer Preclinical Models
  著者:: Cassell, Andre, 等
  出版事項: (2012)